Facial Skin Ablative Treatment Market Research Report: By Technology, Application, Demography - Global Industry Analysis and Demand Forecast to 2030

1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Technology
1.3.2 Market Segmentation by Application
1.3.3 Market Segmentation by Demography
1.3.4 Market Segmentation by Region
1.3.5 Analysis Period
1.3.6 Market Data Reporting Unit
1.4 Key Stakeholders

2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Currency Conversion Rates
2.6 Assumptions for the Study
2.7 Notes & Caveats

4.1 Definition of Market Segments
4.1.1 By Technology
4.1.1.1 Radiofrequency (RF) microneedling
4.1.1.2 Dermal fillers
4.1.1.3 Laser skin resurfacing
4.1.1.4 Mesotherapy
4.1.2 By Application
4.1.2.1 Wrinkles
4.1.2.2 Aging
4.1.2.3 Acne and other scars
4.1.2.4 Hyperpigmentation
4.1.2.5 Others
4.1.3 By Demography
4.1.3.1 Baby boomers
4.1.3.2 Generation X
4.1.3.3 Generation Y
4.1.3.4 Generation Z
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Rising inclination toward improved appearance
4.2.2 Drivers
4.2.2.1 Increasing awareness through seminars and conferences
4.2.2.2 Surging geriatric population
4.2.2.3 Rising disposable income
4.2.2.4 Growing medical tourism industry
4.2.2.5 Increasing volume of anti-aging cosmetic procedures
4.2.2.6 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Stringent regulatory requirements
4.2.3.2 Risks and side-effects associated with facial skin ablative treatment products
4.2.3.3 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Unmet need for minimally or non-invasive treatments
4.2.4.1 Extensive research leading to technical innovations
4.3 Impact of COVID-19
4.4 Porter’s Five Forces Analysis

5.1 By Technology
5.2 By Application
5.3 By Demography
5.4 By Region

6.1 By Technology
6.2 By Application
6.3 By Demography
6.4 By Country
6.4.1 U.S. Facial Skin Ablative Treatment Market
6.4.1.1 By technology
6.4.1.2 By application
6.4.1.3 By demography
6.4.2 Canada Facial Skin Ablative Treatment Market
6.4.2.1 By technology
6.4.2.2 By application
6.4.2.3 By demography

7.1 By Technology
7.2 By Application
7.3 By Demography
7.4 By Country
7.4.1 Germany Facial Skin Ablative Treatment Market
7.4.1.1 By technology
7.4.1.2 By application
7.4.1.3 By demography
7.4.2 France Facial Skin Ablative Treatment Market
7.4.2.1 By technology
7.4.2.2 By application
7.4.2.3 By demography
7.4.3 U.K. Facial Skin Ablative Treatment Market
7.4.3.1 By technology
7.4.3.2 By application
7.4.3.3 By demography
7.4.4 Italy Facial Skin Ablative Treatment Market
7.4.4.1 By technology
7.4.4.2 By application
7.4.4.3 By demography
7.4.5 Spain Facial Skin Ablative Treatment Market
7.4.5.1 By technology
7.4.5.2 By application
7.4.5.3 By demography

8.1 By Technology
8.2 By Application
8.3 By Demography
8.4 By Country
8.4.1 China Facial skin ablative treatment market
8.4.1.1 By technology
8.4.1.2 By application
8.4.1.3 By demography
8.4.2 Japan Facial Skin Ablative Treatment Market
8.4.2.1 By technology
8.4.2.2 By application
8.4.2.3 By demography
8.4.3 India Facial Skin Ablative Treatment Market
8.4.3.1 By technology
8.4.3.2 By application
8.4.3.3 By demography
8.4.4 Australia Facial Skin Ablative Treatment Market
8.4.4.1 By technology
8.4.4.2 By application
8.4.4.3 By demography

9.1 By Technology
9.2 By Application
9.3 By Demography
9.4 By Country
9.4.1 Brazil Facial Skin Ablative Treatment Market
9.4.1.1 By technology
9.4.1.2 By application
9.4.1.3 By demography

10.1 By Technology
10.2 By Application
10.3 By Demography
10.4 By Country
10.4.1 Saudi Arabia Facial Skin Ablative Treatment Market
10.4.1.1 By technology
10.4.1.2 By application
10.4.1.3 By demography

11.1 Strategic Developments of Key Players
11.1.1 Product Launches
11.1.2 Mergers and Acquisitions
11.1.3 Others
11.2 Major Players and Their Offering

12.1 Alma Lasers Ltd.
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.2 Lumenis Ltd.
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.3 Syneron Medical Ltd.
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.4 Cutera Inc.
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.4.3 Key Financial Summary
12.5 Sciton Inc.
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.6 EL.EN. S.p.A.
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.6.3 Key Financial Summary
12.7 Laseroptek Co. Ltd.
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.8 Fotona D.o.o.
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.9 Imdad LLC
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.10 Hologic Inc.
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.10.3 Key Financial Summary
12.11 Stryker Corporation
12.11.1 Business Overview
12.11.2 Product and Service Offerings
12.11.3 Key Financial Summary
12.12 Crown Laboratories Inc.
12.12.1 Business Overview
12.12.2 Product and Service Offerings
12.13 Delasco LLC
12.13.1 Business Overview
12.13.2 Product and Service Offerings
12.14 Lutronic Corp.
12.14.1 Business Overview
12.14.2 Product and Service Offerings
12.15 INSTITUTE BCN ESTHETICS SL
12.15.1 Business Overview
12.15.2 Product and Service Offerings
12.16 Koru Pharmaceuticals Co. Ltd.
12.16.1 Business Overview
12.16.2 Product and Service Offerings
12.17 CAREGEN Co. LTD.
12.17.1 Business Overview
12.17.2 Product and Service Offerings
12.18 HUGEL Inc.
12.18.1 Business Overview
12.18.2 Product and Service Offerings
12.19 Allergan plc
12.19.1 Business Overview
12.19.2 Product and Service Offerings
12.19.3 Key Financial Summary
12.20 Galderma SA
12.20.1 Business Overview
12.20.2 Product and Service Offerings
12.21 Merz Pharma GmbH & Co. KGaA
12.21.1 Business Overview
12.21.2 Product and Service Offerings
12.21.3 Key Financial Summary
12.22 Shenb Co. Ltd.
12.22.1 Business Overview
12.22.2 Products & Services

13.1 Abbreviations
13.2 Sources and References
13.3 Related Reports

TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 GDP PER CAPITA, BASED ON PURCHASING POWER PARITY (PPP), USD (2015-2018)
TABLE 3 COSMETIC PROCEDURES PERFORMED WORLDWIDE IN 2018
TABLE 4 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 5 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 6 MINIMALLY AND NON-INVASIVE ANTI-AGING TREATMENTS
TABLE 7 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 8 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 9 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 10 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 11 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 12 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 13 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY REGION, $M (2014-2019)
TABLE 14 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY REGION, $M (2020-2030)
TABLE 15 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 16 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 17 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 18 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 19 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 20 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 21 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
TABLE 22 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
TABLE 23 U.S. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 24 U.S. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 25 U.S. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 26 U.S. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 27 U.S. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 28 U.S. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 29 CANADA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 30 CANADA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 31 CANADA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 32 CANADA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 33 CANADA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 34 CANADA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 35 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 36 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 37 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 38 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 39 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 40 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 41 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
TABLE 42 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
TABLE 43 GERMANY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 44 GERMANY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 45 GERMANY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 46 GERMANY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 47 GERMANY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 48 GERMANY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 49 FRANCE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 50 FRANCE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 51 FRANCE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 52 FRANCE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 53 FRANCE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 54 FRANCE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 55 U.K. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 56 U.K. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 57 U.K. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 58 U.K. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 59 U.K. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 60 U.K. FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 61 SURGICAL AND NON-SURGICAL COSMETIC PROCEDURES PERFORMED IN ITALY (2018)
TABLE 62 ITALY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 63 ITALY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 64 ITALY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 65 ITALY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 66 ITALY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 67 ITALY FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 68 SPAIN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 69 SPAIN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 70 SPAIN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 71 SPAIN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 72 SPAIN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 73 SPAIN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 74 APAC FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 75 APAC FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 76 APAC FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 77 APAC FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 78 APAC FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 79 APAC FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 80 APAC FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
TABLE 81 APAC FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
TABLE 82 CHINA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 83 CHINA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 84 CHINA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 85 CHINA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 86 CHINA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 87 CHINA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 88 JAPAN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 89 JAPAN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 90 JAPAN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 91 JAPAN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 92 JAPAN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 93 JAPAN FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 94 INDIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 95 INDIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 96 INDIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 97 INDIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 98 INDIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 99 INDIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 100 AUSTRALIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 101 AUSTRALIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 102 AUSTRALIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 103 AUSTRALIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 104 AUSTRALIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 105 AUSTRALIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 106 LATAM FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 107 LATAM FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 108 LATAM FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 109 LATAM FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 110 LATAM FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 111 LATAM FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 112 LATAM FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
TABLE 113 LATAM FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
TABLE 114 BRAZIL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 115 BRAZIL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 116 BRAZIL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 117 BRAZIL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 118 BRAZIL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 119 BRAZIL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 120 MEA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 121 MEA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 122 MEA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 123 MEA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 124 MEA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 125 MEA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 126 MEA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
TABLE 127 MEA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
TABLE 128 SAUDI ARABIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
TABLE 129 SAUDI ARABIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
TABLE 130 SAUDI ARABIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2019)
TABLE 131 SAUDI ARABIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2020-2030)
TABLE 132 SAUDI ARABIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2019)
TABLE 133 SAUDI ARABIA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2020-2030)
TABLE 134 MAJOR PLAYERS AND THEIR OFFERINGS
TABLE 135 ALMA LASERS LTD. - AT A GLANCE
TABLE 136 LUMENIS LTD. - AT A GLANCE
TABLE 137 SYNERON MEDICAL LTD. - AT A GLANCE
TABLE 138 CUTERA INC. - AT A GLANCE
TABLE 139 CUTERA INC. - KEY FINANCIAL SUMMARY
TABLE 140 SCITON INC. - AT A GLANCE
TABLE 141 EL.EN. S.P.A. - AT A GLANCE
TABLE 142 EL.EN. S.P.A. - KEY FINANCIAL SUMMARY
TABLE 143 LASEROPTEK CO. LTD. - AT A GLANCE
TABLE 144 FOTONA D.O.O. - AT A GLANCE
TABLE 145 IMDAD LLC - AT A GLANCE
TABLE 146 HOLOGIC INC. - AT A GLANCE
TABLE 147 HOLOGIC INC. - KEY FINANCIAL SUMMARY
TABLE 148 STRYKER CORPORATION - AT A GLANCE
TABLE 149 STRYKER CORPORATION - KEY FINANCIAL SUMMARY
TABLE 150 CROWN LABORATORIES INC. - AT A GLANCE
TABLE 151 DELASCO LLC - AT A GLANCE
TABLE 152 LUTRONIC CORP. - AT A GLANCE
TABLE 153 INSTITUTE BCN ESTHETICS SL - AT A GLANCE
TABLE 154 KORU PHARMACEUTICALS CO. LTD. - AT A GLANCE
TABLE 155 CAREGEN CO. LTD. - AT A GLANCE
TABLE 156 HUGEL INC. - AT A GLANCE
TABLE 157 ALLERGAN PLC - AT A GLANCE
TABLE 158 ALLERGAN PLC - KEY FINANCIAL SUMMARY
TABLE 159 GALDERMA SA - AT A GLANCE
TABLE 160 MERZ PHARMA GMBH & CO. KGAA - AT A GLANCE
TABLE 161 MERZ PHARMA GMBH & CO. KGAA - KEY FINANCIAL SUMMARY
TABLE 162 SHENB CO. LTD. - AT A GLANCE

FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
FIG 7 DATA TRIANGULATION APPROACH
FIG 8 CURRENCY CONVERSION RATES FOR USD (2020)
FIG 9 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET SUMMARY
FIG 10 AGING POPULATION AS PERCENTAGE OF TOTAL POPULATION IN MAJOR REGIONS (2019 AND 2050)
FIG 11 AVERAGE PERCENTAGE OF MEDICAL TOURISTS WHO UNDERWENT ANTI-AGING PROCEDURES IN DIFFERENT COUNTRIES (2018)
FIG 12 BARGAINING POWER OF BUYERS
FIG 13 BARGAINING POWER OF SUPPLIERS
FIG 14 INTENSITY OF RIVALRY
FIG 15 THREAT OF NEW ENTRANTS
FIG 16 THREAT OF SUBSTITUTES
FIG 17 SNAPSHOT OF GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET
FIG 18 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 19 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2030)
FIG 20 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2030)
FIG 21 GLOBAL FACIAL SKIN ABLATIVE TREATMENT MARKET, BY REGION, $M (2014-2030)
FIG 22 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET SNAPSHOT
FIG 23 PLASTIC SURGERIES AND COSMETIC AND AESTHETIC PROCEDURES PERFORMED IN THE U.S. (2019)
FIG 24 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 25 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2030)
FIG 26 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2030)
FIG 27 NORTH AMERICA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
FIG 28 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET SNAPSHOT
FIG 29 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 30 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2030)
FIG 31 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2030)
FIG 32 EUROPE FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
FIG 33 APAC FACIAL SKIN ABLATIVE TREATMENT MARKET SNAPSHOT
FIG 34 APAC FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 35 APAC FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2030)
FIG 36 APAC FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2030)
FIG 37 APAC FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
FIG 38 LATAM FACIAL SKIN ABLATIVE TREATMENT MARKET SNAPSHOT
FIG 39 LATAM FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 40 LATAM FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2030)
FIG 41 LATAM FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2030)
FIG 42 LATAM FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
FIG 43 MEA FACIAL SKIN ABLATIVE TREATMENT MARKET SNAPSHOT
FIG 44 MEA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY TECHNOLOGY, $M (2014-2030)
FIG 45 MEA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY APPLICATION, $M (2014-2030)
FIG 46 MEA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY DEMOGRAPHY, $M (2014-2030)
FIG 47 MEA FACIAL SKIN ABLATIVE TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
FIG 48 CUTERA INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 49 EL.EN. S.P.A. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 50 HOLOGIC INC. - REVENUE SPLIT BY PRODUCT SEGMENT AND GEOGRAPHY (2020)
FIG 51 STRYKER CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 52 ALLERGAN PLC - REVENUE SPLIT BY PRODUCT SEGMENT (2019)
FIG 53 MERZ PHARMA GMBH & CO. KGAA - REVENUE SPLIT BY GEOGRAPHY (2019)